An Extension of Your Practice
in your Patient’s Home
Introducing the first home-based telemedicine system for patients with age-related macular degeneration: The ForeseeHome™ AMD Monitoring Program.
It’s widely accepted that treatment of choroidal neovascularization when visual acuity is still good and lesions are small results in better visual outcomes.
The ForeseeHome AMD Monitor is the first FDA cleared system for home-based monitoring of patients at risk of vision loss from wet age-related macular degeneration and is the frequent monitoring solution needed for true early detection.
The Notal Vision Data Monitoring Center continuously monitors your patients using the ForeseeHome AMD Monitor and is committed to providing you timely information to supplement your patient care.
The ForeseeHome AMD Monitoring Program is an extension of your practice in your patient’s home.
